Sunday, December 14, 2025
ADVT 
International

Ukrainians need support, not resettlement: UNHCR

Darpan News Desk The Canadian Press, 01 Mar, 2022 10:51 AM
  • Ukrainians need support, not resettlement: UNHCR

OTTAWA — The Canadian representative for the United Nations refugee agency, the UNHCR, says it's too early to begin to resettle Ukrainian refugees who have fled Russian aggression in their country by the thousands.

Rema Jamous says the scale of displacement from Ukraine is daunting, as some 500,000 people have already fled to neighbouring countries seeking safety.

If trends continue, the UNHCR estimates there could be as many as four million Ukrainian refugees.

Still, Jamous says most people who left Ukraine hope to return home when it is safe to do so.

In the meantime, she says, refugees inside and outside of Ukraine's borders will need humanitarian support, as current resources are likely to be depleted quickly.

The UNHCR will discuss resettlement options with countries like Canada at a later stage, but Jamous says typically the demand from people looking for a new home far outstrips the opportunities offered by governments.

MORE International ARTICLES

Prince Harry says ignorance no excuse for unconscious bias

Prince Harry says ignorance no excuse for unconscious bias
Harry talked about racial inequality and social justice in a video discussion with the Black Lives Matter activist Patrick Hutchinson as part of the GQ Heroes Conference, which is being broadcast this week.

Prince Harry says ignorance no excuse for unconscious bias

Halloween goes on at the White House with a few twists

Halloween goes on at the White House with a few twists
In years past, the president and first lady personally handed out candy to the costume-clad kids. This year, the treats were provided separately as participants walked along a path on the South Lawn.

Halloween goes on at the White House with a few twists

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II